Johnson & Johnson

Pharmaceuticals
United States
Earnings Per Share Growth (%)-3.86%
Cost of Goods Sold (US$ Millions)$21,536
Current Liabilities (US$ Millions)$27,747
Total Assets (US$ Millions)$60,210
Long Term Debt$12,857
Return on Equity22.09%
Revenue (US$ Millions)$70,074
Total Company Assets$133,411
Revenue Growth (%)-5.73%
Net Income (US$ Millions)$15,409
Earnings Per Share (US$)($3.86)
Total Equity (US$ Millions)$71,150
Profit Margin (%)21.99%
Debt To Equity Ratio (%)0.18%
Inventory Turnover$8,053